Aviax Ii Plus Stafac Patent Expiration

Aviax Ii Plus Stafac is a drug owned by PHIBRO ANIMAL HEALTH CORP. It is protected by 1 US drug patent filed in 2016. All patents have expired. Details of Aviax Ii Plus Stafac’s patents and their expiration are given below.

Filter patents by

Drug Patent Number Drug Patent Expiry Status
Patent Data
US5736151 Active

About Aviax Ii Plus Stafac

Aviax Ii Plus Stafac is a drug owned by PHIBRO ANIMAL HEALTH CORP. Aviax Ii Plus Stafac uses Semduramicin Sodium, Virginiamycin as the active ingredients.

Active Ingredient:

Aviax Ii Plus Stafac uses Semduramicin Sodium, Virginiamycin as the active ingredients. Check out other Drugs and Companies using Semduramicin Sodium, Virginiamycin ingredient.